Olivier Ingster

Angers, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Angers, FR 

Overview

Olivier Ingster practices practicing medicine in Angers, France.

His clinical expertise encompasses Ruvalcaba Syndrome, Pineoblastoma, Familial Atypical Multiple Mole Melanoma Syndrome, and Familial Pancreatic Cancer.

He is actively involved in clinical research, co-authoring 18 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Angers, France
Other Locations
Nancy, France
Nantes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Study of Family COsegregation of Nucleotide VARiants in the Panel of Genes to Validate Their Use in Genetic Counseling
Study of Family COsegregation of Nucleotide VARiants in the Panel of Genes to Validate Their Use in Genetic Counseling
Enrollment Status: Recruiting
Publish Date: September 01, 2026
Intervention Type: Genetic
Study Phase: Not Applicable
Evaluation of the Circulating Concentration of Olfactomédine 4 (OLFM4) in Women With a BRCA1 or 2 Gene Mutation or at High Risk of Developing Breast Cancer, According to the Imaging
Evaluation of the Circulating Concentration of Olfactomédine 4 (OLFM4) in Women With a BRCA1 or 2 Gene Mutation or at High Risk of Developing Breast Cancer, According to the Imaging
Enrollment Status: Active_not_recruiting
Publish Date: August 15, 2025
Intervention Type: Biological
Study Phase: Not Applicable
View 1 Less Clinical Trial

18 Total Publications

Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study).
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study).
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 22, 2025

Frequently Asked Questions about Olivier Ingster

Is Olivier Ingster a top-rated expert for Ruvalcaba Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Olivier Ingster is classified as an Experienced expert for Ruvalcaba Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Olivier Ingster participate in research or clinical trials?

Yes. Olivier Ingster has published 18 articles and abstracts on conditions like Ruvalcaba Syndrome. You can view a list of Olivier Ingster's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ingster's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile